Overpriced Hip Implants: Doctors Often Have the Final Say in Purchasing

The Swiss healthcare system, renowned for its quality, is facing a significant challenge with the exorbitant cost of medical technology. Our investigation at the Neue Zürcher Zeitung reveals that prices for essential items like hip and knee implants are double those in Germany, and pacemakers are a staggering five times more expensive. This disparity places an immense burden not only on patients through higher insurance premiums but also on hospitals struggling with profitability.

“

Der Arzt hat beim Einkauf von Implantaten oft das letzte Wort

A key factor identified is the substantial say doctors have in the procurement of these devices. While hospitals should be motivated to cut costs, their efforts are often thwarted by physician influence. As Harry Wüst from the health insurer Helsana points out, "The doctor often has the final word in the purchase of implants." This is partly due to legal considerations, where courts give significant weight to a doctor's therapeutic choice based on expertise and patient needs.

Furthermore, doctors, particularly senior physicians and attending physicians who rent facilities, can exert considerable pressure. They often demand the newest, most expensive products, and may even threaten to leave the hospital if their demands aren't met. This leverage, especially in competitive urban areas, significantly weakens the hospitals' negotiating position with powerful medical technology corporations.

“

Die Ärzte verlangen oft die neusten Produkte. Kauft das Spital diese nicht ein, drohen manche damit, die Stelle zu wechseln

From a Swiss perspective, this situation is particularly concerning. We pride ourselves on efficiency and value, yet these inflated prices suggest a systemic issue where patient care and cost-effectiveness are being undermined by a complex interplay of physician influence and corporate power. Addressing this requires a critical look at the purchasing processes within our hospitals and a stronger stance from hospital management in negotiating with suppliers, despite the challenges posed by medical professionals' preferences.

“

Allerdings sind auch die Ärzte an fairen Einkaufspreisen interessiert und haben eine wichtige Rolle, um die steigenden Gesundheitskosten einzudämmen